Note Agreements in the Health Care Equipment & Supplies Industry

1,595 Contracts & Agreements

Browse by Company

Abbott Laboratories (17 contracts)
ABIOMED Inc (2)
Accelerate Diagnostics, Inc (6)
ACCURAY INC (1)
AdvanSource Biomaterials Corp (2)
AETHLON MEDICAL INC (14)
AIT Therapeutics, Inc. (1)
Akari Therapeutics Plc (1)
ALLIED HEALTHCARE PRODUCTS INC (2)
Alphatec Holdings, Inc. (6)
AMERICAN BIO MEDICA CORP (3)
Angiodynamics Inc (2)
Apollo Endosurgery, Inc. (2)
APPYEA, INC (4)
Apyx Medical Corp (2)
AquaMed Technologies, Inc. (5)
ARATANA THERAPEUTICS, INC. (1)
Arch Therapeutics, Inc. (73)
ARGOS THERAPEUTICS INC (4)
Arno Therapeutics, Inc (1)
ATRION CORP (1)
AV Therapeutics, Inc. (2)
Avinger Inc (1)
AxoGen, Inc. (4)
Axonics Modulation Technologies, Inc. (2)
Baxter International Inc. (14)
Becton Dickinson (56)
BIOCANCELL THERAPEUTICS INC. (1)
BIOLASE, INC (1)
BIOLIFE SOLUTIONS INC (12)
BIOMIMETIC THERAPEUTICS, INC. (1)
Bionik Laboratories Corp. (52)
BioSig Technologies, Inc. (4)
Bluejay Diagnostics, Inc. (2)
Boston Scientific (23)
BRAIN SCIENTIFIC INC. (34)
Cadrenal Therapeutics, Inc. (5)
Cascadian Therapeutics, Inc. (1)
CERUS CORP (1)
CESCA THERAPEUTICS INC. (15)
CHEMBIO DIAGNOSTICS, INC. (3)
Chromocell Therapeutics Corp (36)
CLARUS THERAPEUTICS INC (1)
Co-Diagnostics, Inc. (6)
Conformis Inc (1)
CONMED Corporation (19)
CORNERSTONE THERAPEUTICS INC (1)
Coya Therapeutics, Inc. (1)
Cryoport, Inc. (7)
Cutera, Inc. (1)
CV THERAPEUTICS INC (4)
Cytosorbents Corp (3)
D8 Holdings Corp. (5)
Danaher Corp. (3)
DarioHealth Corp. (1)
DELCATH SYSTEMS, INC. (9)
Dentsply Sirona (1)
DYNATRONICS CORP (1)
Eargo, Inc. (1)
Echo Therapeutics, Inc. (18)
EKSO BIONICS HOLDINGS, INC. (1)
electroCore, Inc. (1)
Electromed, Inc. (2)
Electromedical Technologies, Inc (44)
EMBER THERAPEUTICS, INC. - NY (2)
EMULATE THERAPEUTICS, INC. (9)
ENCISION INC (4)
ENDOLOGIX INC (14)
ENDRA Life Sciences Inc. (5)
ERBA Diagnostics, Inc. (13)
FEMASYS INC (1)
GI DYNAMICS, INC. (31)
Glolex, Inc. (20)
GUIDED THERAPEUTICS INC (34)
Hancock Jaffe Laboratories, Inc. (18)
HealthCor Catalio Acquisition Corp. (1)
Heart Test Laboratories, Inc. (10)
HELIUS MEDICAL TECHNOLOGIES, INC. (2)
Hill-Rom Holdings Inc. (2)
Holly Brothers Pictures, Inc. (7)
Hologic (9)
HYPERION THERAPEUTICS INC (3)
HYPERTENSION DIAGNOSTICS INC (2)
ICU Medical (1)
IDEXX Laboratories (5)
IMARX THERAPEUTICS INC (1)
Innovative Eyewear Inc (3)
Integrity Applications, Inc. (3)
INTRICON CORP (10)
Invacare Corporation (4)
Invea Therapeutics, Inc (5)
INVIVO THERAPEUTICS HOLDINGS CORP. (4)
INVO Bioscience, Inc. (19)
iRhythm Technologies, Inc. (2)
IRIDEX CORP (2)
KEWAUNEE SCIENTIFIC CORP (1)
LeMaitre Vascular, Inc. (3)
Longview Acquisition Corp. (2)
Lucid Diagnostics Inc. (2)
MAGNA LAB INC (58)
Masimo (1)
Medifirst Solutions, Inc. (12)
Medite Cancer Diagnostics, Inc. (7)
Medtronic plc (2)
MELINTA THERAPEUTICS, INC. (3)
Meridian Bioscience, Inc. (4)
MICRO THERAPEUTICS INC (2)
Microbot Medical Inc. (3)
MICRON SOLUTIONS INC (5)
MILESTONE SCIENTIFIC INC. (1)
MISONIX INC (1)
Modular Medical, Inc. (4)
Motus GI Holdings, Inc. (1)
MRI INTERVENTIONS, INC. (5)
MYOMO INC (9)
NanoVibronix, Inc. (27)
Nemaura Medical Inc. (9)
Neogen Corporation (1)
Neuronetics, Inc. (4)
NEUROONE MEDICAL TECHNOLOGIES Corp (19)
NEXEON MEDSYSTEMS INC (3)
NON INVASIVE MONITORING SYSTEMS INC (84)
OBALON THERAPEUTICS INC (2)
Ocata Therapeutics, Inc. (3)
ORCHESTRA THERAPEUTICS, INC. (5)
Orexigen Therapeutics, Inc. (2)
ORTHOPEDIATRICS CORP (10)
OSIRIS THERAPEUTICS, INC. (9)
OxySure Therapeutics, Inc. (9)
OZOP SURGICAL CORP. (27)
PAVmed Inc. (8)
PERNIX THERAPEUTICS HOLDINGS, INC. (3)
PetVivo Holdings, Inc. (15)
PRECISION OPTICS CORPORATION, INC. (87)
Precision Therapeutics Inc. (35)
Presbia PLC (1)
Primus Therapeutics Inc. (1)
PRO DEX INC (9)
Pulse Biosciences, Inc. (1)
Q Therapeutics, Inc. (2)
QUANTRX BIOMEDICAL CORP (7)
Quotient Ltd (1)
Ra Medical Systems, Inc. (11)
REMEDENT, INC. (1)
RemSleep Holdings Inc. (13)
ReShape Lifesciences Inc. (1)
ResMed (3)
Restoration Robotics, Inc. (24)
RETRACTABLE TECHNOLOGIES INC (1)
ReWalk Robotics Ltd. (1)
RTI Surgical Holdings, Inc. (4)
RxSight, Inc. (1)
Salona Global Medical Device Corp (3)
Sandbridge Acquisition Corp (1)
SANUWAVE Health, Inc. (37)
SECOND SIGHT MEDICAL PRODUCTS INC (2)
Senseonics Holdings, Inc. (6)
Sensus Healthcare, Inc. (2)
Sharps Technology Inc. (3)
Sientra, Inc. (3)
Sintx Technologies, Inc. (12)
STAAR SURGICAL CO (5)
STEMLINE THERAPEUTICS INC (1)
Stereotaxis, Inc. (5)
STERIS Ltd (10)
STERIS plc (9)
STRATA Skin Sciences, Inc. (5)
Stryker Corp. (5)
Synvista Therapeutics, Inc. (1)
Talon Therapeutics, Inc. (1)
Targanta Therapeutics Corp. (3)
TearLab Corp (3)
TechCare Corp. (10)
Teleflex Inc (3)
Tenon Medical, Inc. (17)
THC Therapeutics, Inc. (4)
The Cooper Companies (2)
Tivic Health Systems, Inc. (7)
Tobira Therapeutics, Inc. (2)
TRANSENTERIX INC. (7)
TransMedics Group, Inc. (1)
United Health Products, Inc. (2)
UTAH MEDICAL PRODUCTS INC (1)
Valeritas Holdings Inc. (5)
VASO Corp (1)
VERMILLION, INC. (4)
VIVEVE MEDICAL, INC. (3)
VIVOS INC (3)
WOUND MANAGEMENT TECHNOLOGIES, INC. (13)
Xtant Medical Holdings, Inc. (4)
Zander Therapeutics, Inc (2)
Zimmer Biomet Holdings (4)
ZimVie Inc. (1)
Zosano Pharma Corp (11)
ZYNEX INC (4)

Recent Contracts

Promissory Note, dated July 23, 2024, in the amount of $50,000 (GUIDED THERAPEUTICS INC, Filed With SEC on November 14, 2024)
Form of Promissory Note issued to Directors (GUIDED THERAPEUTICS INC, Filed With SEC on November 14, 2024)
Amendment No.1 to Master Revolving Note between the Company and Comerica Bank, dated as of October 16, 2024 (Sensus Healthcare, Inc., Filed With SEC on November 14, 2024)
Senior Convertible Promissory Note, dated August 7, 2024, by and between the Registrant and Lind Global Asset Management IX LLC (IRIDEX CORP, Filed With SEC on November 12, 2024)
Form of Amendment No. 4 to the First 2024 Notes (Arch Therapeutics, Inc., Filed With SEC on November 4, 2024)
Form of Amendment No. 6 to the Fourth 2022 Notes (Arch Therapeutics, Inc., Filed With SEC on November 4, 2024)
Form of Amendment No. 15 to the Third 2022 Notes (Arch Therapeutics, Inc., Filed With SEC on November 4, 2024)
Form of Amendment No. 20 to the Second 2022 Notes (Arch Therapeutics, Inc., Filed With SEC on November 4, 2024)
Form of Amendment No. 20 to the First 2022 Notes (Arch Therapeutics, Inc., Filed With SEC on November 4, 2024)
Form of Seller Note (KEWAUNEE SCIENTIFIC CORP, Filed With SEC on November 1, 2024)
Promissory Note of Non-Invasive Monitoring Systems, Inc. in favor of Frost Gamma Investments Trust dated October 23, 2024 (NON INVASIVE MONITORING SYSTEMS INC, Filed With SEC on October 25, 2024)
Form of Note, dated as of October 16, 2024 (OBALON THERAPEUTICS INC, Filed With SEC on October 17, 2024)
Modification and Amendment of Promissory Note dated September 30, 2024 by and between Precision Optics Corporation, Inc. and Main Street Bank (PRECISION OPTICS CORPORATION, INC., Filed With SEC on September 30, 2024)
Modification and Amendment of Term Note dated September 30, 2024 by and between Precision Optics Corporation, Inc. and Main Street Bank (PRECISION OPTICS CORPORATION, INC., Filed With SEC on September 30, 2024)
Promissory Note of Non-Invasive Monitoring Systems, Inc. in favor of Frost Gamma Investments Trust dated September 25, 2024 (NON INVASIVE MONITORING SYSTEMS INC, Filed With SEC on September 27, 2024)
Form of Promissory Note, dated September 26, 2024, of Venus Concept USA Inc (Restoration Robotics, Inc., Filed With SEC on September 27, 2024)
Form of Senior Secured Note (Sharps Technology Inc., Filed With SEC on September 23, 2024)
Form of Amendment No. 3 to the First 2024 Notes (Arch Therapeutics, Inc., Filed With SEC on September 19, 2024)
Form of Amendment No. 5 to the Fourth 2022 Notes (Arch Therapeutics, Inc., Filed With SEC on September 19, 2024)
Form of Amendment No. 14 to the Third 2022 Notes (Arch Therapeutics, Inc., Filed With SEC on September 19, 2024)
Form of Amendment No. 19 to the Second 2022 Notes (Arch Therapeutics, Inc., Filed With SEC on September 19, 2024)
Form of Amendment No. 19 to the First 2022 Notes (Arch Therapeutics, Inc., Filed With SEC on September 19, 2024)
Promissory Note dated September 6, 2024 (Heart Test Laboratories, Inc., Filed With SEC on September 10, 2024)
Note Purchase Agreement, by and between the Company and Streeterville Capital, LLC dated September 6, 2024 (Heart Test Laboratories, Inc., Filed With SEC on September 10, 2024)
First Amendment to Promissory Note dated July 25, 2024 (Ra Medical Systems, Inc., Filed With SEC on August 27, 2024)
First Amendment to Promissory Notes dated June 25, 2024, July 1, 2024 and July 18, 2024 (Ra Medical Systems, Inc., Filed With SEC on August 27, 2024)
First Amendment to Promissory Note dated May 30, 2024 (Ra Medical Systems, Inc., Filed With SEC on August 27, 2024)
First Amendment to 8% Short Term Promissory Note Payable to Jenkins Family Charitable Institute (Ra Medical Systems, Inc., Filed With SEC on August 27, 2024)
First Amendment to 8% Short Term Promissory Note Payable to David A. Jenkins (Ra Medical Systems, Inc., Filed With SEC on August 27, 2024)
First Amendment to 8% Short Term Promissory Notes Payable to FatBoy Capital, L.P (Ra Medical Systems, Inc., Filed With SEC on August 27, 2024)
No. 2 Amended and Restated Secured Promissory Note by and between Heart Test Laboratories, Inc. and Front Range Ventures LLC dated August 19, 2024 (Heart Test Laboratories, Inc., Filed With SEC on August 21, 2024)
Form of Convertible Promissory Note, dated May 10, 2024, by and between Akari Therapeutics, Plc and the purchasers party thereto (Akari Therapeutics Plc, Filed With SEC on August 19, 2024)
Form of Amendment No. 2 to the First 2024 Notes (Arch Therapeutics, Inc., Filed With SEC on August 16, 2024)
Form of Amendment No. 4 to the Fourth 2022 Notes (Arch Therapeutics, Inc., Filed With SEC on August 16, 2024)
Form of Amendment No. 13 to the Third 2022 Notes (Arch Therapeutics, Inc., Filed With SEC on August 16, 2024)
Form of Amendment No. 18 to the Second 2022 Notes (Arch Therapeutics, Inc., Filed With SEC on August 16, 2024)
Form of Amendment No. 18 to the First 2022 Notes (Arch Therapeutics, Inc., Filed With SEC on August 16, 2024)
$62,100 Promissory Note Dated July 22, 2024 with 1800 Diagonal Lending (GUIDED THERAPEUTICS INC, Filed With SEC on August 14, 2024)
$100,050 Promissory Note Dated June 11, 2024 with 1800 Diagonal Lending (GUIDED THERAPEUTICS INC, Filed With SEC on August 14, 2024)
Form of 4.75% Convertible Senior Notes due February 15, 2030 (ORTHOPEDIATRICS CORP, Filed With SEC on August 12, 2024)